SEC Form D private-offering filing

Remedium Bio Inc.

Name: Remedium Bio Inc. - new SEC Form D private-offering filing, Needham, MA
Published: 2026-05-18

A new SEC Form D private-offering notice from Needham, MA, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Remedium Bio Inc. site↗ Verified via SEC Form D

Developer of the Prometheus adjustable gene therapy platform for treating osteoarthritis, obesity, type 2 diabetes and stroke.

Filed 2026-05-18Filed to raise $10,000,000First money in 2026-05-06Raised so far $1,500,000HQ (as filed) Needham, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified remedium-bio.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.